Author

Barbara H. Waberski

Observed names: B. H. Waberski, Barbara Waberski

Observed institutions: Hartford Hospital, Mayo Clinic, University of Connecticut, George Washington University, University of Michigan, Michigan Medicine, Bureau of Health Workforce, UConn Health

OpenAlex ID: A5043504000

Effect of Prior Intensive Insulin Treatment During the Diabetes Control and Complications Trial (DCCT) on Peripheral Neuropathy in Type 1 Diabetes During the Epidemiology of Diabetes Interventions and Complications (EDIC) Study

2010 · James W. Albers, William H. Herman, et al. · Diabetes Care · 400

Neuropathy Among the Diabetes Control and Complications Trial Cohort 8 Years After Trial Completion

2006 · Catherine L. Martin, James Albers, et al. · Diabetes Care · 350

Effects of Prior Intensive Insulin Therapy on Cardiac Autonomic Nervous System Function in Type 1 Diabetes Mellitus

2009 · Rodica Pop-Busui, Phillip A. Low, et al. · Circulation · 310

Biomedical risk factors for decreased cognitive functioning in type 1 diabetes: an 18 year follow-up of the Diabetes Control and Complications Trial (DCCT) cohort

2010 · A. M. Jacobson, C. M. Ryan, et al. · Diabetologia · 169

DCCT and EDIC Studies in Type 1 Diabetes: Lessons for Diabetic Neuropathy Regarding Metabolic Memory and Natural History

2010 · Rodica Pop-Busui, William H. Herman, et al. · Current Diabetes Reports · 130

Impact of Diabetes and Its Treatment on Cognitive Function Among Adolescents Who Participated in the Diabetes Control and Complications Trial

2008 · Gail Musen, Alan M. Jacobson, et al. · Diabetes Care · 127

Extending the preoxygenation period from 4 to 8 mins in critically ill patients undergoing emergency intubation*

2008 · Thomas C. Mort, Barbara H. Waberski, et al. · Critical Care Medicine · 97

Vibration Perception Threshold as a Measure of Distal Symmetrical Peripheral Neuropathy in Type 1 Diabetes

2010 · Catherine L. Martin, Barbara H. Waberski, et al. · Diabetes Care · 81

Subclinical Neuropathy Among Diabetes Control and Complications Trial Participants Without Diagnosable Neuropathy at Trial Completion

2007 · James W. Albers, William H. Herman, et al. · Diabetes Care · 59

The associations of apolipoprotein E and angiotensin‐converting enzyme polymorphisms and cognitive function in Type 1 diabetes based on an 18‐year follow‐up of the DCCT cohort

2009 · A. M. Jacobson, A. D. Paterson, et al. · Diabetic Medicine · 15

Glycemic Control and Hypoglycemia: Is the Loser the Winner?

2009 · Gail Musen, Alan M. Jacobson, et al. · Diabetes Care · 3

Works count: 14

Citation count: 1,741

H-index: 10

I10-index: 10